RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 3,125
- Locations
- 1
- Primary Endpoint
- Assess cardiovascular risk of the study population
Study Overview
Brief Summary
This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.
Detailed Description
Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.
Clinical history, physical examination and complementary tests are being performed.
Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the "Virgen de la Salud" hospital of Toledo.
CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender
Exclusion Criteria
- •Individulas aged under 18 years.
- •Subjects who do not sign the informed consent.
- •Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.
Outcomes
Primary Outcomes
Assess cardiovascular risk of the study population
Time Frame: December 2020
Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Prevalence of cardiovascular risk factors
Time Frame: December 2020
To assess the prevalence of cardiovascular risk factors
Prevalence of cardiovascular disease
Time Frame: December 2020
To assess the prevalence of cardiovascular disease
Secondary Outcomes
No secondary outcomes reported
Investigators
Gustavo Rodriguez Roca
Director & principal Investigator, Clinical Professor
Castilla-La Mancha Health Service